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Summary
The antiinflammatory action of aspirin is generally attributed to inhibition of cyclooxygenases 1 and 2, but additional mechanisms are at work.
These include inhibition of NF k B translocation to the nucleus and the capacity of aspirin to promote accumulation of adenosine, a potent
antiinflammatory autocoid. We tested these hypotheses in the murine air pouch model of acute inflammation in wild type mice and in
cyclooxygenase 2 or NF k B knockouts. The antiinflammatory effects of aspirin, sodium salicylate and indomethacin did not correlate with
inhibition of cyclooxygenase in either group. Indeed, aspirin retained its antiinflammatory properties even in COX-2 knockouts. Similarly,
aspirin was no less antiinflammatory in mice rendered deficient for NF k B (p105) than in wild type controls. In contrast, dexamethasone lost
its antiinflammatory capacity in NFk B knockouts. Aspirin and sodium salicylate dramatically increased concentrations of adenosine in
exudates, a property shared with methotrexate and sulfasalazine. Removal of adenosine by adenosine deaminase or specific antagonism
of adenosine at A2 receptors completely reversed the antiinflammatory effects of aspirin and sodium salicylate, but not those of
dexamethasone. This adenosine-dependent, antiinflammatory effect of aspirin points to another target of drug development.
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Much of what we know about antiinflammation has come
from studies of salicylates, the oldest class of anti-
inflammatory agents still in use. Since Vane’s discovery,1
many of aspirin’s effects have been traced to inhibition of
prostaglandin synthesis. However, not all can be accounted
for by simple inhibition of cyclooxygenases 1 and 2
(COX-1,2). For example, therapeutic serum concentrations
of salicylate, a poor inhibitor of COX-1,2, correlate better
with clinical antiinflammation than serum concentrations of
aspirin (reviewed in 2). Indeed we have found that aspirin
and sodium salicylate inhibit neutrophil activation by inter-
fering with signal transduction pathways independent of
prostaglandin synthesis3 while others have reported that
aspirin and sodium salicylate, but not other inhibitors of
COX-1 and 2, disrupt signal transduction between cell
surface receptors and transcription of ‘inflammatory’
mediators by inhibiting intracellular traffic of NFKB.4
Recently, Serhan’s laboratory has found that aspirin, but
not sodium salicylate, promotes synthesis of such novel
antiinflammatory eicosanoids as 15-epi-lipoxin A4. Finally,
we have demonstrated in vitro that pharmacologically
relevant concentrations of sodium salicylate promote
breakdown of intracellular ATP, thereby releasing micro-
molar amounts of the potent antiinflammatory autocoid,
adenosine, into extracellular fluids.5
To analyze the antiinflammatory effects of aspirin and
sodium salicylate in vivo, we compared their inhibition
of carrageenan-induced inflammation with that of the
equipotent COX-1,2 inhibitor, indomethacin, and with361dexamethasone. We also compared their efficacy in wild
type mice with that in animals with targeted disruption of
COX-2 or NFk B (p105). Finally, we determined whether the
effects of salicylates were due to extracellular adenosine by
comparing the sensitivity of their antiinflammatory action to
adenosine deaminase and to a selective adenosine A2
antagonist.Materials and methods
MATERIALS
3,7-Dimethyl-l-propargylxanthine (DMPX) was obtained
from Research Biochemicals, Inc. (Wayland, MA). Adeno-
sine deaminase (Type IV, calf intestinal), aspirin, indo-
methacin, sodium salicylate and dexamethasone and
carrageenan were obtained from Sigma Chemical Co. (St
Louis, MO). BALB/c mice were obtained from Taconic
Animal Farms (NY). NFk B knockout (pl05) and COX-2
knockout mice were obtained from the Jackson Labora-
tories (Bar Harbor, ME) and bred in the animal facilities of
New York University Medical Center. No contamination of
the breeding animals was detected by genetic (PCR)
testing of DNA from these animals (data not shown).*Address correspondence to: E-mail: cronsb01@mcrcr6.med.
nyu.edu; Fax: 212-263-8804; Tel: 212-263-6404.EFFECT OF DRUGS ON CARRAGEENAN-INDUCED INFLAMMATION
IN THE MURINE AIR POUCH
To induce an air pouch, mice were injected sub-
cutaneously with 3 cc of air (on the back) three times per
week. The mice were administered 200 mg/kg of aspirin or
sodium salicylate, or mg/kg of indomethacin by gastric
362 B. N. Cronstein et al.: Sites of action for future therapygavage in a final volume of 200 ml once a day for four days;
control animals were given a similar volume of saline for
three days. On the third day of administration of drugs or
saline the air pouch was injected with 1 ml of a 2% (w/v)
suspension of carrageenan and mice were returned to their
cages where they were allowed to run free for four hours.
The animals were then killed, 2 cc of normal saline was
injected into the pouch and the contents of the pouch
aspirated, diluted 1:2 with normal saline and samples taken
for cell count. Smears of the undiluted fluid were prepared
and stained (Wright-Giemsa) revealing that >95% of the
exudate cells were PMNs.INJECTION OF ADENOSINE DEAMINASE AND ADENOSINE
RECEPTOR ANTAGONISTS
In some experiments adenosine deaminase (0.125 IU/
mI) or DMPX (10 mM) was added to the carrageenan
suspension but the final volume of the carrageenan sus-
pension (with inhibitors) did not differ from that in control
mice (1 ml).ADENOSINE DETERMINATION
Aliquots of pouch exudates were added to a similar
volume of trichloroacetic acid (10%vfv) followed by extrac-
tion of the organic acid with freon/trioctylamine (77.5%/
22.5%, v/v). The adenosine concentration of the
supernatants was determined by reverse-phase HPLC, as
we have previously described. Briefly, samples were
applied to a C18mBondapack column (Waters Assoc.,
Milford, MA) and eluted with a 0–40% linear gradient
(formed over 60 min) of 0.01 M ammonium phosphate
(pH 5.5) and methanol, with a 1.5 ml/min flow rate. Adeno-
sine was identified by retention time and the characteristic
UV ratio of absorbance at 250/260 and the concentration
was calculated by comparison to standards. Similarly, no
adenosine peak was observed in chromatograms of pouch
exudates from animals treated with injections of adenosine
deaminase into the pouch (data not shown). Preliminary
studies demonstrated that 90% of added adenosine was
recovered using this technique.5
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Fig. 1. Aspirin and sodium salicylate are antiinflammatory in the
murine air pouch model of inflammation. Effects of adenosine
deaminase and an A 2 receptor antagonist. After treatment of mice
with aspirin (200 mg/kg), sodium salicylate (200 mg/kg) or vehicle
inflammation was induced as described, the inflammatory
exudates harvested and the leukocytes quantitated. Adenosine
deaminase (0.125 IU/mI) or 3,7-Dimethyl-1-propargylxanthine
(DMPX; 10 mM) were added to carrageenan suspension as indi-
cated. The results shown represent the mean (±SEM) of 6–9
different animals. , Control; , ASA; , NaS.5
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Fig. 2. Aspirin is antiinflammatory in COX2 knockout mice. After
treatment of mice with aspirin (200 mg/kg) or vehicle inflammation
was induced as described, the inflammatory exudates harvested
and the leukocytes quantitated. The results shown represent the
mean of four and five different animals, respectively. , Control;
, ASA.
Results
When wild-type mice were treated with oral aspirin or
sodium salicylate for three days, carrageenan-induced
leukocyte accumulation in the air pouch was significantly
decreased (Fig. 1). Aspirin’s pharmacologic precursor and
major metabolite, sodium salicylate, was equipotent
to aspirin in the air pouch model, despite its relative
inadequacy as an in-vitro inhibitor of COX-1,2 In contrast,
treatment with indomethacin failed to affect leukocyte
accumulation in the inflamed air pouch (P=N.S., N=8–9).
These data suggest that indomethacin, the inhibition by
which of carrageenan-induced paw swelling clearly
depends on COX-1 and 2, affects neutrophil accumulation
and edema differentially. Indeed, treatment with aspirin and
indomethacin, but not sodium salicylate, reduced PGE2
accumulation in the air pouch exudate; i.e., there was no
correlation between antiinflammation and inhibition of
COX-1,2. We therefore determined whether aspirin
retained its antiinflammatory properties in animals with
targeted disruption of the gene for COX2: no difference wasfound in the response to aspirin between wild-type animals
and COX 2 knockouts (Fig. 2).
High-dose salicylates (serum levels 2–5 mM) and gluco-
corticoids are equally effective antiinflammatory agents in
acute rheumatism2 and in the air-pouch model. High-dose
salicylates and glucocorticoids also prevent translocation of
NFk B to the nucleus thereby impeding release of ‘inflam-
matory’ mediators and/or cytokines.6 To test the hypothesis
that the in-vivo effects of aspirin and glucocorticoids are
also mediated by NFk B, we compared their effects in
wild-type mice and in animals with targeted disruption of
NFk B (p105). Surprisingly, disruption of NFk B failed to
affect the accumulation of leukocytes in air pouches of wild
type mice (7.8±0.7×106/pouch vs 9.2±2.0×106/pouch,
wild type vs NFk B KO, N=8, P=NS). Nevertheless
although aspirin and salicylate retained their antiinflam-
matory effects in the NFk B knockouts, (NS vs wild-type,
N=8–9), dexamethasone was significantly less antiinflam-
matory (Fig. 3). The results indicate that aspirin and sodium
Osteoarthritis and Cartilage Vol. 7 No. 4 363salicylate inhibit inflammation in vivo by a mechanism that
is independent of NFKB activation, its intracellular traffic, or
indirect effects via iŒB.
Treatment of endothelial cells in vitro with sodium
salicylate increases extracellular concentrations of adeno-
sine, due to increased catabolism of ATP. Since adenosine
mediates the antiinflammatory effects in vivo of metho-
trexate and sulfasalazine,5,6 we determined concentrations
of adenosine in air pouches of control and aspirin-treated
animals. Adenosine concentrations in exudates from
aspirin-treated animals were far greater than from controls
(224±98 nM vs 13±6 nM, respectively, P<0.0I, N=6).
Elimination of extracellular adenosine from the inflam-
matory exudate by addition of adenosine deaminase to the
air pouch completely reversed the antiinflammatory effects
of both aspirin and sodium salicylate while the adenosine
A2 receptor antagonist DMPX also reversed the antiinflam-
matory effect of aspirin (Fig. 1). Neither agent reverses the
inhibition of inflammation by dexamethasone pouch
6model.Discussion
Aspirin not only interferes with eicosanoid metabolism
via COX-1 and 2, but has many other diverse actions: it
interferes with the Raf-1/Mek/Erk signaling cascade, the
integrin-dependent clumping of cells ranging from humanneutrophils to marine sponges, the release of adenosine
and 15-epi-lipoxin A4, and the nuclear translocation of
NFkB.1–6 The results reported here suggest that aspirin is
effective in animals that cannot make prostaglandins via
the ‘antiinflammatory’ cyclooxygenase, COX-2, and equally
effective in animals that lack a major transcription factor for
‘inflammatory’ cytokines, NFk B. They also demonstrate, for
the first time in vivo, that glucorticoids exert their antiinflam-
matory effects by inhibiting white cell influx into inflamma-
tory sites by an NFk B-dependent mechanism, a suggestion
we had previously based on experiments in vitro.
While it is obvious that there is no one model that applies
to ‘inflammation’ in general, the readout of inflammation in
our experiments was the influx of neutrophils into an air
pouch, a more sharply defined measure of inflammation
than simple measurements of soft tissue swelling, or
edema. Our data therefore negate the notion that aspirin-
like drugs work in every sort of inflammatory insult by virtue
of their direct inhibition of cyclooxygenase(s).They suggest,
indeed, a complementary mechanism of action of high-
dose aspirin: extracellular release of adenosine at sites of
inflammation. Whatever the exact mechanism of adenosine
release proves to be, the fact that adenosine mediates the
antiinflammatory effects in vivo of such diverse agents as
aspirin, methotrexate and sulfasalazine points to another
promising target for drug discovery.50
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Fig. 3. Dexamethasone is less effective in NF k B knockout mice.
After treatment of wild type (+/+) or NF k B knockout (−/−) mice
with dexamethasone (0.5 mg/kg) or vehicle inflammation was
induced as described, the inflammatory exudates harvested and
the leukocytes quantitated. The results shown represent the mean
(±SEM) of 6–8 different animals. , Control; , Dexamethasone.References
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